These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 14707570)

  • 1. Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units.
    van Nieuwenhoven CA; Buskens E; Bergmans DC; van Tiel FH; Ramsay G; Bonten MJ
    Crit Care Med; 2004 Jan; 32(1):126-30. PubMed ID: 14707570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.
    Shorr AF; Susla GM; Kollef MH
    Crit Care Med; 2004 Jan; 32(1):137-43. PubMed ID: 14707572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing ventilator-associated pneumonia in a trauma ICU.
    Cocanour CS; Peninger M; Domonoske BD; Li T; Wright B; Valdivia A; Luther KM
    J Trauma; 2006 Jul; 61(1):122-9; discussion 129-30. PubMed ID: 16832259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.
    Shorr AF; Tabak YP; Gupta V; Johannes RS; Liu LZ; Kollef MH
    Crit Care; 2006; 10(3):R97. PubMed ID: 16808853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ventilator-associated pneumonia; controversies with respect to diagnosis, pathogenesis, therapy and prevention].
    Bonten MJ; Bergmans DC; Hoepelman IM; Stobberingh EE
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):726-30. PubMed ID: 10347627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis.
    Branch-Elliman W; Wright SB; Howell MD
    Am J Respir Crit Care Med; 2015 Jul; 192(1):57-63. PubMed ID: 25871807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study.
    Ramírez P; Ferrer M; Gimeno R; Tormo S; Valencia M; Piñer R; Menendez R; Torres A
    Crit Care Med; 2009 May; 37(5):1691-5. PubMed ID: 19325465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients.
    Earley AS; Gracias VH; Haut E; Sicoutris CP; Wiebe DJ; Reilly PM; Schwab CW
    J Trauma; 2006 Jul; 61(1):1-5; discussion 5-7. PubMed ID: 16832243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of ventilator-associated pneumonia on the Canadian health care system.
    Muscedere JG; Martin CM; Heyland DK
    J Crit Care; 2008 Mar; 23(1):5-10. PubMed ID: 18359415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomics of pneumonia.
    Wunderink RG
    Am J Surg; 2000 Feb; 179(2A Suppl):51S-57S. PubMed ID: 10802267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of ventilator associated pneumonia in an intensive care unit].
    Petersen IS; Bonde J
    Ugeskr Laeger; 2007 Dec; 169(49):4268-71. PubMed ID: 18208707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a program of intensive surveillance and interventions targeting ventilated patients in the reduction of ventilator-associated pneumonia and its cost-effectiveness.
    Lai KK; Baker SP; Fontecchio SA
    Infect Control Hosp Epidemiol; 2003 Nov; 24(11):859-63. PubMed ID: 14649776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing ventilator-associated pneumonia rates through a staff education programme.
    Salahuddin N; Zafar A; Sukhyani L; Rahim S; Noor MF; Hussain K; Siddiqui S; Islam M; Husain SJ
    J Hosp Infect; 2004 Jul; 57(3):223-7. PubMed ID: 15236851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection control education: impact on ventilator-associated pneumonia rates in a public sector intensive care unit in Pakistan.
    Khan MS; Siddiqui SZ; Haider S; Zafar A; Zafar F; Khan RN; Afshan K; Jabeen A; Khan MS; Hasan R
    Trans R Soc Trop Med Hyg; 2009 Aug; 103(8):807-11. PubMed ID: 19342068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia.
    Shorr AF; Zilberberg MD; Kollef M
    Infect Control Hosp Epidemiol; 2009 Aug; 30(8):759-63. PubMed ID: 19538095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and impact of aspiration pneumonia in patients undergoing surgery in Maryland, 1999-2000.
    Kozlow JH; Berenholtz SM; Garrett E; Dorman T; Pronovost PJ
    Crit Care Med; 2003 Jul; 31(7):1930-7. PubMed ID: 12847385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention.
    Safdar N; Crnich CJ; Maki DG
    Respir Care; 2005 Jun; 50(6):725-39; discussion 739-41. PubMed ID: 15913465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients.
    Kahn JM; Rubenfeld GD; Rohrbach J; Fuchs BD
    Med Care; 2008 Dec; 46(12):1226-33. PubMed ID: 19300312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.